News Charities unite to oppose NICE rare disease rules MPs to discuss controversial plan in special debate.
Views & Analysis Pharma could take NHS England to court over new delaying tac... New cost-capping and delaying measures will further restrict access to new medicines say pharma and patient groups.
News Pharma attacks plan to ration new drugs in England Plans to ration and delay use of novel drugs in England have been condemned by the pharma industry and a health charity.
News Digital heart scan can save NHS millions HeartFlow could save NHS England a minimum of around £9.1 million by 2022.
News Alexion lambasts NICE over rare disease ruling Watchdog accused of ignoring stakeholder consensus and call for negotiations
Views & Analysis UK Pharmaceutical Leaders Survey 2017: Brace for Turbulence A look ahead to the UK market in 2017 through the eyes of pharma industry leaders
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.